Oscar Health's ACA marketplace expansion fuels growth prospects, but subsidy uncertainty, rising medical costs and pricing risks could challenge lasting profits.
Arcosa (ACA) came out with quarterly earnings of $1.13 per share, missing the Zacks Consensus Estimate of $1.18 per share. This compares to earnings of $1.27 per share a year ago.
While the top- and bottom-line numbers for Arcosa (ACA) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Here is how Arcosa (ACA) and Emcor Group (EME) have performed compared to their sector so far this year.
Investors need to pay close attention to ACA stock based on the movements in the options market lately.
Arcosa stock advances after CRH announced an $8.5 billion deal for the company.
AMTB, ACA and ASH have been added to the Zacks Rank #5 (Strong Sell) List on June 8, 2026.
ACA, BKR and BFC have been added to the Zacks Rank #5 (Strong Sell) List on June 1st, 2026.
Roth conversions look like free money on a spreadsheet: pay tax now at a lower bracket, never pay tax on the growth again.
AKZOY, AMTB and ACA have been added to the Zacks Rank #5 (Strong Sell) List on May 20, 2026.
AUGO, AMTB and ACA have been added to the Zacks Rank #5 (Strong Sell) List on May 8, 2026.
Arcosa, Inc. (ACA) Q1 2026 Earnings Call Transcript